La(iii) biodistribution profiles from intravenous and oral dosing of two lanthanum complexes, La(dpp)3 and La(XT), and evaluation as treatments for bone resorption disorders.

Trivalent lanthanum (La3+) has the potential to treat bone resorption disorders (such as osteoporosis) by eliciting a bone-building response in the cells which control skeletal remodelling. Because La3+ suffers from extremely poor intestinal absorption, specifically designed chelators are required in order that a biologically active form of lanthanum can be administered orally. Two such chelators, 1,2-dimethyl-3-hydroxy-4-pyridinone (Hdpp) and bis-{[bis(carboxymethyl)amino]methy}phosphinic acid (H5XT), have previously been the subjects of extensive physical, in vitro, and in vivo testing as the tris- and mono-lanthanum(iii) complexes La(dpp)3 and La(XT), respectively. In this manuscript, we expand upon those studies to include 4-week intravenous (IV) and oral La3+ biodistribution profiles, which show that the metal ion initially accumulates in the liver followed by preferential redistribution and retention by bone. Of the two compounds, La(XT) demonstrates the more favourable in vivo characteristics, therefore dose-dependent oral biodistribution studies were carried out with this complex. These show drug saturation above a dose of 100 mg kg-1 day-1, so liver histology was performed in order to assess any potential toxicity. Finally, we improve upon the physical characterization of La(dpp)3 to include a single crystal X-ray structure, which exhibits an 8-coorindate La3+ centre with two bound water molecules, and a disordered exoclathrate-type hydrogen bonded network.

Caloric expenditure during cardiac rehabilitation.

PURPOSE: The purpose of this study was to describe estimated caloric expenditure among patients in a maintenance cardiac rehabilitation program relative to a stated goal of approximately 300 kcal/session or 1,000 kcal/week. Additionally, we assessed the validity of several different methods for estimating caloric expenditure. METHODS: The caloric expenditure for an exercise session was evaluated in 30 of 65 patients exercising in a maintenance cardiac rehabilitation program. Patients exercised using a treadmill, dual-action ergometer, upright stepper, or reclining stepper. The kilocalorie expenditure was assessed by three different techniques. The first used liquid crystal display (LCD) readings from the equipment (LCD method), the second combined both the American College of Sports Medicine metabolic equations for treadmill walking and the LCD values from the other equipment (Combined method), and the third measured oxygen consumption (VO2 method). RESULTS: The caloric expenditure for the LCD, Combined, and VO2 methods were 247 +/- 83, 245 +/- 80, and 230 +/- 88 kcal, respectively. Agreement between methods using intraclass correlation analysis was r = 0.84 (0.68 to 0.92, 95% confidence intervals) for LCD versus VO2 and r = 0.88 (0.77 to 0.94, 95% confidence intervals) for Combined versus VO2 method. CONCLUSIONS: Most patients (83%) in a maintenance cardiac rehabilitation program exercise below 300 kcal per session, a level believed to be necessary to illicit favorable changes in cardiovascular health. Additionally, the Combined method provides a reasonable estimate of kilocalorie expenditure. Use of kilocalorie expenditure should be considered in the cardiac rehabilitation setting as a fourth component in the exercise prescription.